Reikvam H - Search Results

1

Altered Immune Activation and IL-23 Signaling in Response to Candida albicans in Autoimmune Polyendocrine Syndrome Type 1.

Bruserud Ø, Bratland E, Hellesen A, Delaleu N, Reikvam H, Oftedal BE, Wolff ASB. Bruserud Ø, et al. Among authors: reikvam h. Front Immunol. 2017 Sep 1;8:1074. doi: 10.3389/fimmu.2017.01074. eCollection 2017. Front Immunol. 2017. PMID: 28919897 Free PMC article.

2

Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia.

Reikvam H, Ersvaer E, Bruserud O. Reikvam H, et al. Curr Cancer Drug Targets. 2009 Sep;9(6):761-76. doi: 10.2174/156800909789271486. Curr Cancer Drug Targets. 2009. PMID: 19754360 Review.

3

The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia.

Hatfield KJ, Reikvam H, Bruserud Ø. Hatfield KJ, et al. Among authors: reikvam h. Curr Med Chem. 2010;17(36):4448-61. doi: 10.2174/092986710794183033. Curr Med Chem. 2010. PMID: 21062258 Review.

4

Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.

Bruserud Ø, Liseth K, Stamnesfet S, Cacic DL, Melve G, Kristoffersen E, Hervig T, Reikvam H. Bruserud Ø, et al. Among authors: reikvam h. Transfus Med. 2013 Dec;23(6):397-406. doi: 10.1111/tme.12067. Epub 2013 Aug 6. Transfus Med. 2013. PMID: 23919332 Review.

5

Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients.

Reikvam H, Øyan AM, Kalland KH, Hovland R, Hatfield KJ, Bruserud Ø. Reikvam H, et al. Cell Prolif. 2013 Oct;46(5):554-62. doi: 10.1111/cpr.12057. Cell Prolif. 2013. PMID: 24073609 Free PMC article.

6

A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic Regulators.

Brenner AK, Reikvam H, Bruserud Ø. Brenner AK, et al. Among authors: reikvam h. Front Immunol. 2016 May 25;7:205. doi: 10.3389/fimmu.2016.00205. eCollection 2016. Front Immunol. 2016. PMID: 27252705 Free PMC article.

7

A prospective observational study on effects of fever on red cell transfusion outcome.

Wendelbo Ø, Netland Opheim E, Felli Lunde TH, Bruserud Ø, Hervig T, Reikvam H. Wendelbo Ø, et al. Among authors: reikvam h. Vox Sang. 2017 Jul;112(5):484-486. doi: 10.1111/vox.12526. Epub 2017 May 18. Vox Sang. 2017. PMID: 28516477

8

Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers.

Reikvam H, Grønningsæter IS, Mosevoll KA, Lindås R, Hatfield K, Bruserud Ø. Reikvam H, et al. Front Immunol. 2018 Jan 24;8:1979. doi: 10.3389/fimmu.2017.01979. eCollection 2017. Front Immunol. 2018. PMID: 29416533 Free PMC article.

9

Inflammatory Mediator Profiles Differ in Sepsis Patients With and Without Bacteremia.

Mosevoll KA, Skrede S, Markussen DL, Fanebust HR, Flaatten HK, Aßmus J, Reikvam H, Bruserud Ø. Mosevoll KA, et al. Among authors: reikvam h. Front Immunol. 2018 Apr 6;9:691. doi: 10.3389/fimmu.2018.00691. eCollection 2018. Front Immunol. 2018. PMID: 29681903 Free PMC article.

10

Successful eradication of leptomeningeal plasma cell disease.

Bruserud Ø, Hansen BA, Vetti N, Johansen S, Reikvam H. Bruserud Ø, et al. Among authors: reikvam h. Oxf Med Case Reports. 2018 Jul 3;2018(7):omy038. doi: 10.1093/omcr/omy038. eCollection 2018 Jul. Oxf Med Case Reports. 2018. PMID: 29992033 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page